{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:19Z","timestamp":1788910399234,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010882","name":"Australasian Society of Clinical Immunology and Allergy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["115423"],"award-info":[{"award-number":["115423"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jaip.2023.12.028","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T11:37:52Z","timestamp":1703590672000},"page":"1019-1028.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy"],"prefix":"10.1016","volume":"12","author":[{"given":"Melanie","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"Lozinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi L.K.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.12.028_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-020-0898-7","article-title":"Epidemiology and burden of food allergy","volume":"20","author":"Warren","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.12.028_bib2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.12.028_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2017.02.019","article-title":"The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up","volume":"140","author":"Peters","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.anai.2014.12.022","article-title":"Treatment of allergic reactions and quality of life among caregivers of food-allergic children","volume":"114","author":"Ward","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00103-016-2368-x","article-title":"Health-related quality of life in food allergy","volume":"59","author":"Dunn Galvin","year":"2016","journal-title":"Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz"},{"key":"10.1016\/j.jaip.2023.12.028_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2023.12.028_bib7","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/j.jaip.2021.07.047","article-title":"Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial","volume":"9","author":"Dunn Galvin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.12.028_bib8","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.12.028_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.12.028_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2017.11.004","article-title":"Treatment for food allergy","volume":"141","author":"Burks","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.941020","article-title":"Measuring the impact of food immunotherapy on health-related quality of life in clinical trials","volume":"3","author":"Lloyd","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2023.12.028_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ACI.0000000000000271","article-title":"Food allergy quality of life and living with food allergy","volume":"16","author":"Greenhawt","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/all.15027","article-title":"Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy","volume":"77","author":"Fernandez-Rivas","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.12.028_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during, and after oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.12.028_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-018-8700-5","article-title":"Psychosocial mediators of change and patient selection factors in oral immunotherapy trials","volume":"55","author":"Dunn Galvin","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1398-9995.2006.01181.x","article-title":"Incorporating a gender dimension in food allergy research: a review","volume":"61","author":"Dunn Galvin","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.12.028_bib17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2222.2010.03454.x","article-title":"Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire\u2013Parent Form in children 0\u201312 years following positive and negative food challenges","volume":"40","author":"Dunn Galvin","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.12.028_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13743","article-title":"The burden of food allergy on children and teens: a systematic review","volume":"33","author":"Golding","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib19","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.jaip.2021.05.020","article-title":"Improvement in health-related quality of life in food-allergic patients: a meta-analysis","volume":"9","author":"Cao","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.12.028_bib20","volume":"10","author":"Lozinsky","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2023.12.028_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2222.2008.02978.x","article-title":"Food allergy QoL questionnaire for children aged 0\u201312 years: content, construct, and cross-cultural validity","volume":"38","author":"Dunn Galvin","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.12.028_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100503","article-title":"Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review","volume":"14","author":"Arasi","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.12.028_bib23","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.12.028_bib25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.rmed.2013.07.024","article-title":"Sex differences in asthma symptom profiles and control in the American Lung Association Asthma Clinical Research Centers","volume":"107","author":"McCallister","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.12.028_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.12891\/ceog4727.2019","article-title":"Use of sympathomimetic amines to correct premenstrual urticaria and anaphylaxis","volume":"46","author":"Check","year":"2019","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.jaip.2023.12.028_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ACI.0000000000000529","article-title":"Gender aspects in food allergy","volume":"19","author":"Pali-Sch\u00f6ll","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ajcn\/nqaa096","article-title":"Supplementation with vitamin D or \u03c9-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial","volume":"112","author":"Nodler","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jaip.2023.12.028_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/biomedicines10020328","article-title":"Sex, allergic diseases and omalizumab","volume":"10","author":"Sirufo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2023.12.028_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.12.028_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaip.2023.01.005","article-title":"Food allergen immunotherapy in preschool children: do we have the evidence?","volume":"11","author":"Loke","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823013910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823013910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:12:34Z","timestamp":1778523154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823013910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2213219823013910"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.12.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}